Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Slični predmeti

• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  od: Kobayashi, Susumu, i dr.
  Izdano: (2013)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  od: Costa, Daniel B, i dr.
  Izdano: (2007)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  od: Daniel B. Costa, i dr.
  Izdano: (2007)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  od: Norihiro Yamaguchi, i dr.
  Izdano: (2013)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  od: Yamaguchi, Norihiro, i dr.
  Izdano: (2013)